Table 2 5-year Overall Survival and Disease-Specific Survival by Anatomic and Prognosis Stage of TNBCs included in SEER cohort (N = 31,941)
Stage | No. at risk | 5-year OS (95% CI) | p-value | No. at risk | 5-year DSS (95% CI) | p-value | |
|---|---|---|---|---|---|---|---|
AS | I | 12,700 | 87.2(86.2,88.0) | < 0.001** | 12,700 | 93.5(82.8,94.2) | < 0.001** |
IA | 12,293 | 87.4(86.5,88.3) | 0.004* | 12,293 | 93.8(93.1,94.4) | 0.001* | |
IB | 407 | 80.4(73.9,85.5) | 407 | 86.2(80.6,90.2) | |||
II | 14,292 | 75.3(74.2,76.4) | < 0.001# | 14,292 | 82.7(81.8,83.7) | < 0.001# | |
IIA | 9713 | 78.5(77.2,79.7) | 9713 | 86.0(84.9,87.0) | |||
IIB | 4579 | 68.3(66.1,70.4) | 4579 | 75.5(73.5,77.4) | |||
III | 4949 | 46.8(44.8,48.7) | < 0.001△ | 4949 | 54.0(52.0,56.0) | < 0.001△ | |
IIIA | 2515 | 57.1(54.3,59.7) | 2515 | 63.6(60.8,66.2) | |||
IIIB | 1164 | 38.5(34.5,42.5) | 1164 | 47.0(42.6,51.2) | |||
IIIC | 1270 | 34.3(30.5,38.2) | 1270 | 41.4(37.3,45.2) | |||
PS | I | 12,293 | 87.4(86.5,88.3) | < 0.001** | 12,293 | 93.8(93.1,94.4) | < 0.001** |
IA | 407 | 89.4(83.6,93.2) | 0.212* | 407 | 94.6(89.2,97.3) | 0.259* | |
IB | 11,886 | 87.4(86.5,88.3) | 11,886 | 93.8(93.1,94.4) | |||
II | 10,726 | 77.9(76.7,79.1) | < 0.001# | 10,726 | 85.5(84.4,86.5) | < 0.001# | |
IIA | 10,120 | 78.6(77.3,79.8) | 10,120 | 86.0(85.0,87.0) | |||
IIB | 606 | 67.4(61.2,72.9) | 606 | 75.4(69.3,80.4) | |||
III | 8922 | 56.3(54.8,57.8) | < 0.001△ | 8922 | 63.5(62.0,65.0) | < 0.001△ | |
IIIA | 3986 | 68.7(66.4,70.8) | 3986 | 75.6(73.4,77.6) | |||
IIIB | 365 | 56.3(47.8,64.0) | 365 | 62.1(53.0,70.0) | |||
IIIC | 4571 | 45.9(43.9,48.0) | 4571 | 53.3(51.2,55.4) |